Global Nasal Spray Market By Overview
Inside the local nasal cavity, the medication is generally delivered through nasal spray. They are used to treat nose allergies for instance, nasal stop up and are used for conditions such as nasal congestion and rhinitis. In some situation rather than injection or pills, nasal delivery route is preferred which immunes the body and reacts to allergic patients. Through the nose substance or drug can be consumed quickly and straight into the nasal cavity. Nasal showers are seen as a more capable strategy for transporting drugs with potential use in crossing point the blood–brain impediment.
Increase in infection and allergic cases, painless drug delivery system and rising awareness among people regarding the availability of generic drugs at a low cost is projected to drive the growth of the global nasal spray market, in the near future. Better alternate for other drug delivery, improvement in patient compliance, exploring therapeutic applications for nasal spray gives an opportunity to the key players of nasal spray to enhance the growth. Nasal drug delivery systems offer benefits, such as noninvasiveness and reduction in lag-time caused due to oral drug delivery. This helps in providing better patient comfort, which improves their adherence for the medication. However, nasal decongestant sprays are safe, but short-term stinging, irritation or sinus dryness are the problem experienced by some patients. The most common side effect of these medications, is rebound congestion.
Global nasal spray market has been segmented on the basis of product type, container design, dosage form, prescription mode, application, therapeutics class and end user.
On the basis of product type, target market it classified into decongestion nasal spray, saline nasal spray, steroid nasal spray. On the basis of container design market is classified into pressurized canisters, pump bottles which keeps the drug in associated surrounding. On the basis of dosage market is divided into unit or single dose, bi-dose, multi-dose according to the patient need. On the basis of prescription mode, the market is classified into over the counter and prescription based. On the basis of application market is classified into nasal congestion, allergic and non-allergic rhinitis, central nervous system disorders, vaccination. On the basis of therapeutic class market is classified into antihistamine, nasal steroids, mast cell Inhibitor and anticholinergic. On the basis of end user, the nasal Spray market is segmented into Pharmacy, Hospitals and clinics.
On the basis of region, Global industrial market has been segmented North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America nasal spray market is expected to account for major revenue share as compared to that of other regions. Also, the market in Europe is expected to account for second-highest revenue share in the global nasal spray market. Moreover, the market in Asia Pacific is projected to witness significant growth over the forecast period due to increase in population as well as industrialization followed by Latin America and Middle east countries.
Key players operating in global nasal spray market include Sandoz international, Catalent pharma limited, Pfizer Incorp., Pfeiffer GMBH private limited, Nastech pharmaceuticals limited , Adapt Pharma, Inc., Innovus pharmaceuticals Limited, Allergan PLC limited, Nephron pharmaceuticals corporation, Cipla Ltd., Media Corporation, Sunovion pharmaceuticals INC., Teva Respiratory LLC., Apotex Corp., Novartis corporation, Valent pharmaceuticals international.
FAQs
Global nasal spray market has been segmented on the basis of product type, container design, dosage form, prescription mode, application, therapeutics class and end user.
Overuse Concerns, Potential Side Effects, Limited Efficacy for Some Conditions, Stringent Regulatory Approval, Market Saturation
Increasing Respiratory Disorders, Convenience of Administration, Technological Advancements, Growing Awareness of Self-Medication
By region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
Key players operating in global nasal spray market include Sandoz international, Catalent pharma limited, Pfizer Incorp., Pfeiffer GMBH private limited, Nastech pharmaceuticals limited , Adapt Pharma, Inc., Innovus pharmaceuticals Limited, Allergan PLC limited, Nephron pharmaceuticals corporation, Cipla Ltd., Media Corporation, Sunovion pharmaceuticals INC., Teva Respiratory LLC., Apotex Corp., Novartis corporation, Valent pharmaceuticals international.